Market Overview:
The global gene panel test kit market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for personalized medicine, rising prevalence of cancer and other genetic disorders, and technological advancements in gene sequencing techniques. Based on type, the global gene panel test kit market can be segmented into amplicon-based approach and hybridization-based approach. The amplicon-based approach segment is expected to account for a larger share of the market than the hybridization-based approach segment during the forecast period. This can be attributed to factors such as lower costs and shorter turnaround times associated with amplicon-based approaches as compared with hybridization-based approaches. Based on application, the global gene panel test kit market can be divided into cancer risk assessment, diagnosis of congenital diseases, pharmacogenetics, and others (including research applications). The cancer risk assessment application segment is projected to register highest CAGR during 2018–2030 owing high incidence rate of various types cancers across globe .Whereas , Diagnosis Of Congenital Diseases Segment Is Expected To Hold Largest Market Share In Terms Of Revenue Till 2030 .
Product Definition:
A gene panel test kit is a device used to identify specific genes in a sample of DNA. The importance of gene panel tests is that they can help doctors diagnose and treat genetic conditions.
Amplicon-based Approach:
Amplicon-based approach is a new technology that involves the use of multiplexed DNA probes for detecting and screening genetic abnormalities in clinical samples. The Amplicon-based gene panel test kit developed by Cepheid can detect over 600 genes at once, which makes it one of the most powerful diagnostic kits available in the market. It helps healthcare professionals to diagnose over 600 diseases with greater accuracy and precision than other conventional methods.
Hybridization-based Approach:
Hybridization-based approach is used for the detection of gene panel test kits. It helps in the identification of novel and rare variants that may not be detected using other approaches. This method is based on hybridization technology wherein DNA probe molecules are designed to an appropriate nucleic acid sequence which can hybridize with any target sequence in a specific manner.
Application Insights:
The application of the gene panel test kits extends to various fields such as pharmacogenetics, diagnosis of congenital diseases, cancer risk assessment and others. The other applications include genetic testing for personalized medicine and research purposes.
Pharmacogenetics is a relatively new field in the medical sector that deals with determining drug response based on an individual¢â‚¬â„¢s genotype/phenotype. This segment is anticipated to grow at a lucrative rate during the forecast period owing to its rising adoption across several disease states including diabetes mellitus, osteoporosis, epilepsy and many more.
Personalized medicine holds great potential in curing numerous chronic conditions due to their root cause being found out through genomic analysis which otherwise would have remained obscure or mysterious.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of clinical research organizations and biotechnology companies involved in genomics-based discovery research. Moreover, increasing investments by pharmaceutical companies for drug development are expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to ongoing genomic studies and technological advancements in laboratories as well as healthcare centers across this region. The availability of raw material at cheaper costs coupled with less stringent government regulations for approval of products has attracted many pharmaceutical manufacturers from developed countries such as U.S., Canada, Germany, and Japan for setting up manufacturing facilities in Asia Pacific Gene Technology Center (APGTDC). Thus, these factors are expected to boost revenue generation from gene panels tests across APAC during the forecast period (2018 - 2030).
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of genetic disorders
- Technological advancements in gene panel testing
- Growing awareness about the benefits of gene panel testing
- Increasing number of private and public sector initiatives to promote gene panel testing
Scope Of The Report
Report Attributes
Report Details
Report Title
Gene Panel Test Kit Market Research Report
By Type
Amplicon-based Approach, Hybridization-based Approach
By Application
Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, Others
By Companies
Illumina, Thermo Fisher, Agilent, Qiagen, Eurofins Scientific, BGI, Roche, Integrated Dna Technologies, Genewiz, Novogene, Illumina, Gatc Biotech, Archerdx
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Gene Panel Test Kit Market Report Segments:
The global Gene Panel Test Kit market is segmented on the basis of:
Types
Amplicon-based Approach, Hybridization-based Approach
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- Thermo Fisher
- Agilent
- Qiagen
- Eurofins Scientific
- BGI
- Roche
- Integrated Dna Technologies
- Genewiz
- Novogene
- Illumina
- Gatc Biotech
- Archerdx
Highlights of The Gene Panel Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Amplicon-based Approach
- Hybridization-based Approach
- By Application:
- Cancer Risk Assessment
- Diagnosis of Congenital Diseases
- Pharmacogenetics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gene Panel Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gene panel test kit is a set of tests that can help identify genetic abnormalities.
Some of the major players in the gene panel test kit market are Illumina, Thermo Fisher, Agilent, Qiagen, Eurofins Scientific, BGI, Roche, Integrated Dna Technologies, Genewiz, Novogene, Illumina, Gatc Biotech, Archerdx.
The gene panel test kit market is expected to grow at a compound annual growth rate of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gene Panel Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gene Panel Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gene Panel Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gene Panel Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gene Panel Test Kit Market Size & Forecast, 2018-2028
4.5.1 Gene Panel Test Kit Market Size and Y-o-Y Growth
4.5.2 Gene Panel Test Kit Market Absolute $ Opportunity
Chapter 5 Global Gene Panel Test Kit Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Gene Panel Test Kit Market Size Forecast by Type
5.2.1 Amplicon-based Approach
5.2.2 Hybridization-based Approach
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Gene Panel Test Kit Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Gene Panel Test Kit Market Size Forecast by Applications
6.2.1 Cancer Risk Assessment
6.2.2 Diagnosis of Congenital Diseases
6.2.3 Pharmacogenetics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gene Panel Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gene Panel Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Gene Panel Test Kit Analysis and Forecast
9.1 Introduction
9.2 North America Gene Panel Test Kit Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Gene Panel Test Kit Market Size Forecast by Type
9.6.1 Amplicon-based Approach
9.6.2 Hybridization-based Approach
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Gene Panel Test Kit Market Size Forecast by Applications
9.10.1 Cancer Risk Assessment
9.10.2 Diagnosis of Congenital Diseases
9.10.3 Pharmacogenetics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Gene Panel Test Kit Analysis and Forecast
10.1 Introduction
10.2 Europe Gene Panel Test Kit Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Gene Panel Test Kit Market Size Forecast by Type
10.6.1 Amplicon-based Approach
10.6.2 Hybridization-based Approach
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Gene Panel Test Kit Market Size Forecast by Applications
10.10.1 Cancer Risk Assessment
10.10.2 Diagnosis of Congenital Diseases
10.10.3 Pharmacogenetics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Gene Panel Test Kit Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Gene Panel Test Kit Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Gene Panel Test Kit Market Size Forecast by Type
11.6.1 Amplicon-based Approach
11.6.2 Hybridization-based Approach
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Gene Panel Test Kit Market Size Forecast by Applications
11.10.1 Cancer Risk Assessment
11.10.2 Diagnosis of Congenital Diseases
11.10.3 Pharmacogenetics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Gene Panel Test Kit Analysis and Forecast
12.1 Introduction
12.2 Latin America Gene Panel Test Kit Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Gene Panel Test Kit Market Size Forecast by Type
12.6.1 Amplicon-based Approach
12.6.2 Hybridization-based Approach
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Gene Panel Test Kit Market Size Forecast by Applications
12.10.1 Cancer Risk Assessment
12.10.2 Diagnosis of Congenital Diseases
12.10.3 Pharmacogenetics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Gene Panel Test Kit Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Gene Panel Test Kit Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Gene Panel Test Kit Market Size Forecast by Type
13.6.1 Amplicon-based Approach
13.6.2 Hybridization-based Approach
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Gene Panel Test Kit Market Size Forecast by Applications
13.10.1 Cancer Risk Assessment
13.10.2 Diagnosis of Congenital Diseases
13.10.3 Pharmacogenetics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gene Panel Test Kit Market: Competitive Dashboard
14.2 Global Gene Panel Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina
14.3.2 Thermo Fisher
14.3.3 Agilent
14.3.4 Qiagen
14.3.5 Eurofins Scientific
14.3.6 BGI
14.3.7 Roche
14.3.8 Integrated Dna Technologies
14.3.9 Genewiz
14.3.10 Novogene
14.3.11 Illumina
14.3.12 Gatc Biotech
14.3.13 Archerdx
